» Articles » PMID: 33584737

SiRNA Specificity: RNAi Mechanisms and Strategies to Reduce Off-Target Effects

Overview
Journal Front Plant Sci
Date 2021 Feb 15
PMID 33584737
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Short interfering RNAs (siRNAs) are processed from long double-stranded RNA (dsRNA), and a guide strand is selected and incorporated into the RNA-induced silencing complex (RISC). Within RISC, a member of the Argonaute protein family directly binds the guide strand and the siRNA guides RISC to fully complementary sites on-target RNAs, which are then sequence-specifically cleaved by the Argonaute protein-a process commonly referred to as RNA interference (RNAi). In animals, endogenous microRNAs (miRNAs) function similarly but do not lead to direct cleavage of the target RNA but to translational inhibition followed by exonucleolytic decay. This is due to only partial complementarity between the miRNA and the target RNA. SiRNAs, however, can function as miRNAs, and partial complementarity can lead to miRNA-like off-target effects in RNAi applications. Since siRNAs are widely used not only for screening but also for therapeutics as well as crop protection purposes, such miRNA-like off-target effects need to be minimized. Strategies such as RNA modifications or pooling of siRNAs have been developed and are used to reduce off-target effects.

Citing Articles

Evaluating the pathogenic and immunological effects of ds-GFP as a control in in vivo RNA interference studies of Schistosoma japonicum.

Xiu L, Wang X, Cheng S, Liu W, Wang L, Li J Parasite. 2025; 32:16.

PMID: 40008812 PMC: 11863600. DOI: 10.1051/parasite/2025003.


Theoretical perspectives and clinical applications of non-coding RNA in lung cancer metastasis: a systematic review.

Yang J, Luo Y, Yao Z, Wang Z, Jiang K Discov Oncol. 2025; 16(1):169.

PMID: 39937377 PMC: 11822152. DOI: 10.1007/s12672-025-01919-3.


Development and evaluation of siRNA-mediated gene silencing strategies for ADO2 therapy utilizing iPSCs model and DMPC-SPIONs delivery system.

Xu J, Chen G, Mo C, Sha Y, Luo S, Ou M Stem Cell Res Ther. 2025; 16(1):66.

PMID: 39934917 PMC: 11816505. DOI: 10.1186/s13287-025-04151-6.


Exogenous dsRNA-Mediated RNAi: Mechanisms, Applications, Delivery Methods and Challenges in the Induction of Viral Disease Resistance in Plants.

Venu E, Ramya A, Babu P, Srinivas B, Kumar S, Reddy N Viruses. 2025; 17(1).

PMID: 39861836 PMC: 11769437. DOI: 10.3390/v17010049.


Epigenetic regulation of HOXA2 expression affects tumor progression and predicts breast cancer patient survival.

De Palma F, Pol J, Carbonnier V, Scuderi S, Mannino D, Montegut L Cell Death Differ. 2025; .

PMID: 39833374 DOI: 10.1038/s41418-024-01430-2.


References
1.
Mi S, Cai T, Hu Y, Chen Y, Hodges E, Ni F . Sorting of small RNAs into Arabidopsis argonaute complexes is directed by the 5' terminal nucleotide. Cell. 2008; 133(1):116-27. PMC: 2981139. DOI: 10.1016/j.cell.2008.02.034. View

2.
Sheu-Gruttadauria J, MacRae I . Structural Foundations of RNA Silencing by Argonaute. J Mol Biol. 2017; 429(17):2619-2639. PMC: 5576611. DOI: 10.1016/j.jmb.2017.07.018. View

3.
Zhang H, Kolb F, Brondani V, Billy E, Filipowicz W . Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J. 2002; 21(21):5875-85. PMC: 131079. DOI: 10.1093/emboj/cdf582. View

4.
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J . The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003; 425(6956):415-9. DOI: 10.1038/nature01957. View

5.
Han J, Lee Y, Yeom K, Kim Y, Jin H, Kim V . The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 2004; 18(24):3016-27. PMC: 535913. DOI: 10.1101/gad.1262504. View